Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.

Black SW, Morairty SR, Chen TM, Leung AK, Wisor JP, Yamanaka A, Kilduff TS.

J Neurosci. 2014 May 7;34(19):6485-94. doi: 10.1523/JNEUROSCI.0080-14.2014.

2.

Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.

Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS.

Sleep. 2013 Mar 1;36(3):325-36. doi: 10.5665/sleep.2442.

3.

Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Tabuchi S, Tsunematsu T, Black SW, Tominaga M, Maruyama M, Takagi K, Minokoshi Y, Sakurai T, Kilduff TS, Yamanaka A.

J Neurosci. 2014 May 7;34(19):6495-509. doi: 10.1523/JNEUROSCI.0073-14.2014.

4.

Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.

Huang YS, Guilleminault C.

Pediatr Neurol. 2009 Jul;41(1):9-16. doi: 10.1016/j.pediatrneurol.2009.02.008.

PMID:
19520267
5.

Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset.

Sato M, Sagawa Y, Hirai N, Sato S, Okuro M, Kumar S, Kanbayashi T, Shimizu T, Sakai N, Nishino S.

Exp Neurol. 2014 Nov;261:744-51. doi: 10.1016/j.expneurol.2014.08.004. Epub 2014 Aug 10.

6.

Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.

Scrima L, Hartman PG, Johnson FH Jr, Hiller FC.

Biol Psychiatry. 1989 Aug;26(4):331-43.

PMID:
2669980
7.

Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric Acid, and Baclofen on EEG activity and sleep regulation.

Vienne J, Bettler B, Franken P, Tafti M.

J Neurosci. 2010 Oct 20;30(42):14194-204. doi: 10.1523/JNEUROSCI.3145-10.2010.

8.

Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.

Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y.

Sleep Med Rev. 2012 Oct;16(5):431-43. doi: 10.1016/j.smrv.2011.09.001. Epub 2011 Nov 4. Review.

PMID:
22055895
9.

Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice.

Fujiki N, Cheng T, Yoshino F, Nishino S.

Exp Neurol. 2009 May;217(1):46-54. doi: 10.1016/j.expneurol.2009.01.015. Epub 2009 Feb 3.

10.

Baclofen and gamma-hydroxybutyrate differentially altered behavior, EEG activity and sleep in rats.

Hodor A, Palchykova S, Gao B, Bassetti CL.

Neuroscience. 2015 Jan 22;284:18-28. doi: 10.1016/j.neuroscience.2014.08.061. Epub 2014 Oct 6.

PMID:
25301745
11.
13.

Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.

Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M.

J Neurosci. 2004 May 5;24(18):4469-77.

14.

[Narcolepsy: a new perspective on diagnosis and treatment].

Fronczek R, van der Zande WL, van Dijk JG, Overeem S, Lammers GJ.

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):856-61. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2007 Jun 2;151(22):1260.

PMID:
17472116
15.

The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.

Weinhold SL, Seeck-Hirschner M, Nowak A, Hallschmid M, Göder R, Baier PC.

Behav Brain Res. 2014 Apr 1;262:8-13. doi: 10.1016/j.bbr.2013.12.045. Epub 2014 Jan 7.

PMID:
24406723
16.

Behavioral state instability in orexin knock-out mice.

Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T, Scammell TE.

J Neurosci. 2004 Jul 14;24(28):6291-300.

17.

Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy.

Plazzi G, Pizza F, Vandi S, Aricò D, Bruni O, Dauvilliers Y, Ferri R.

Sleep Med. 2014 Sep;15(9):1046-54. doi: 10.1016/j.sleep.2014.04.020. Epub 2014 Jun 4.

PMID:
25087195
18.

Mechanism of action of narcolepsy medications.

Gowda CR, Lundt LP.

CNS Spectr. 2014 Dec;19 Suppl 1:25-33; quiz 25-7, 34. doi: 10.1017/S1092852914000583. Epub 2014 Nov 18. Review.

PMID:
25403789
19.

[Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].

Poza-Aldea JJ.

Rev Neurol. 2009 Jan 1-15;48(1):27-31. Review. Spanish.

20.

The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.

Scrima L, Hartman PG, Johnson FH Jr, Thomas EE, Hiller FC.

Sleep. 1990 Dec;13(6):479-90.

PMID:
2281247
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk